Yin Shi, Zhang Bao, Li Tian, Li Xingxuan, Xie Zongjun, Tang Hao, Wang Yi, Wen Tianlin, Jia Zhiwei, Wu Yaohong
Department of Orthopedics, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
Department of Orthopedics, Guangyuan Central Hospital, Guangyuan, China.
Orthop J Sports Med. 2025 May 16;13(5):23259671251337481. doi: 10.1177/23259671251337481. eCollection 2025 May.
Platelet-rich plasma (PRP) has been utilized as adjunctive therapy in arthroscopic rotator cuff repair. However, there is currently limited research available on the efficacy of PRP in arthroscopic repair of full-thickness rotator cuff tears.
This study aimed to perform a cross-sectional analysis of overlapping meta-analyses comparing the clinical efficacy of arthroscopic repair of full-thickness rotator cuff tears with and without PRP to assist clinicians in assessing the most reliable evidence and formulating treatment recommendations accordingly.
Systematic review; Level of evidence, 2.
Under PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, comprehensive searches of meta-analyses were performed in the PubMed, Embase, and Cochrane Library databases until June 1, 2024, and found 63 studies. The methodological quality of the included studies was evaluated using the Assessment of Multiple Systematic Reviews (AMSTAR) and Oxford Centre for Evidence-Based Medicine Levels of Evidence instruments. Data extraction from the included meta-analyses was independently performed by 2 reviewers. The Jadad decision algorithm was employed to identify meta-analyses with the most robust evidence.
This study included 5 meta-analyses. These meta-analyses had AMSTAR scores ranging from 7 to 9, with a mean of 8. The most reliable evidence, assessed by the Jadad algorithm, included 8 randomized controlled trials and involved 566 patients. It showed that the short-term (≤12 months after surgery) retear rate and visual analog scale score were significantly lower in those with PRP than in those without PRP. The short-term Constant score, short-term University of California, Los Angeles (UCLA) activity score, and long-term (>12 months after surgery) UCLA score were significantly higher in the PRP group, especially in single-row fixation.
Our study demonstrates that the most reliable evidence suggests that PRP injections can be recommended as adjunctive therapy in single-row repair for enhanced short-term outcomes. Further high-quality randomized controlled trials are imperative to increase the strength of evidence.
富血小板血浆(PRP)已被用作关节镜下肩袖修复的辅助治疗。然而,目前关于PRP在关节镜下全层肩袖撕裂修复中疗效的研究有限。
本研究旨在对重叠的荟萃分析进行横断面分析,比较使用和不使用PRP的关节镜下全层肩袖撕裂修复的临床疗效,以帮助临床医生评估最可靠的证据并据此制定治疗建议。
系统评价;证据等级,2级。
按照PRISMA(系统评价和荟萃分析的首选报告项目)指南,在PubMed、Embase和Cochrane图书馆数据库中对荟萃分析进行全面检索,截至2024年6月1日,共找到63项研究。使用多重系统评价评估(AMSTAR)和牛津循证医学中心证据等级工具对纳入研究的方法学质量进行评估。由2名审阅者独立从纳入的荟萃分析中提取数据。采用Jadad决策算法识别证据最充分的荟萃分析。
本研究纳入了5项荟萃分析。这些荟萃分析的AMSTAR评分在7至9分之间,平均分为8分。通过Jadad算法评估,最可靠的证据包括8项随机对照试验,涉及566例患者。结果显示,在短期(术后≤12个月),使用PRP的患者再撕裂率和视觉模拟量表评分显著低于未使用PRP的患者。PRP组的短期Constant评分、短期加州大学洛杉矶分校(UCLA)活动评分和长期(术后>12个月)UCLA评分显著更高,尤其是在单排固定中。
我们的研究表明,最可靠的证据表明,PRP注射可推荐作为单排修复的辅助治疗,以改善短期疗效。进一步开展高质量的随机对照试验对于增强证据力度至关重要。